Conduct Mock Recalls Periodically to Strengthen GMP Readiness

Perform Periodic Mock Recalls to Test Your GMP Recall Preparedness

Remember: GMP-compliant facilities are required to conduct mock recalls regularly to evaluate recall systems, ensure batch traceability, and reinforce regulatory readiness.

Why This Matters in GMP

A mock recall is a simulated exercise where a facility practices the process of withdrawing a batch from the market to test its ability to respond to product quality concerns. These exercises are not just regulatory requirements—they serve as diagnostic tools to assess the effectiveness of the recall procedure, communication plans, traceability systems, and documentation practices. They also help identify weak points, such as incomplete distribution records, delayed response times, or gaps in QA oversight.

Also Read: Schedule M (Revised) GMP Requirements for Pharmaceutical Packaging and Labeling

Mock recalls create awareness among staff, validate recall SOPs, and ensure that in a real event—such as product contamination, labeling error, or adverse drug reaction—the facility can act swiftly and precisely. Failure to conduct or poorly performing in a mock recall could be a precursor to actual failure in a real-life scenario.

Regulatory and Compliance Implications

FDA 21 CFR Part 211.150 mandates written procedures for product recall and periodic testing of those procedures. EU GMP Chapter 8 requires that recall systems be periodically challenged to ensure

effectiveness. WHO GMP and Schedule M stipulate mock recalls as a standard practice for evaluating and improving recall procedures. Auditors often request mock recall reports, assess traceability timeframes, and verify closure documentation. Lack of mock recall exercises or failure to reach recall objectives during testing are flagged as quality system deficiencies.

Also Read: The Role of GMP in Ensuring Safe and Effective Transportation of Pharmaceuticals

Implementation Best Practices

Plan and conduct mock recalls at least annually, rotating product categories and recall scenarios.
Ensure complete traceability from raw materials to distribution endpoints using documented batch records.
Simulate different types of recalls (e.g., voluntary, regulatory-mandated) and monitor recall speed and accuracy.
Include QA, production, logistics, regulatory affairs, and sales departments in recall response teams.
Document the entire exercise, identify gaps, implement CAPA, and update SOPs based on findings.

Regulatory References

FDA 21 CFR Part 211.150 – Product Recall Procedures
EU GMP Chapter 8 – Recall Preparedness and Effectiveness
WHO GMP – Periodic Mock Recall Testing
Schedule M – Product Recall System Evaluation

Also Read: The Challenges and Best Practices of GMP Compliance for IMPs in Long-Term Clinical Trials